Contact Information
37 Westminster Buildings, Theatre Square,
Nottingham, NG1 6LG
Healthcare/Life Sciences
![Hedge Funds Seek to Cut Off $1 Billion Meant for Opioid Victims](http://www.nasdaqpicks.com/wp-content/uploads/2023/07/Hedge-Funds-Seek-to-Cut-Off-1-Billion-Meant-for-400x400.jpeg)
Hedge Funds Seek to Cut Off $1 Billion Meant for Opioid Victims
- By nasdaqpicks.com
- . 26 July 2023
Drugmaker Mallinckrodt is talking to hedge funds about filing for bankruptcy and avoiding payments intended to help people addicted to opioids. Source link
![U.K. Reviews Safety of Ozempic, Other Weight-Loss Drugs](http://www.nasdaqpicks.com/wp-content/uploads/2023/07/UK-Reviews-Safety-of-Ozempic-Other-Weight-Loss-Drugs-400x400.jpeg)
U.K. Reviews Safety of Ozempic, Other Weight-Loss Drugs
- By nasdaqpicks.com
- . 26 July 2023
Drug regulators said they have received several reports of suspected suicidal and self-injurious behavior in patients taking the drugs. Source link
![Biogen to Cut Roughly 11% of Workforce](http://www.nasdaqpicks.com/wp-content/uploads/2023/07/Biogen-to-Cut-Roughly-11-of-Workforce-400x400.jpeg)
Biogen to Cut Roughly 11% of Workforce
- By nasdaqpicks.com
- . 25 July 2023
The biotech cited the launch of Alzheimer’s drug Leqembi as part of its new focus on big-return products. Source link
![Dove Maker Unilever Still Raising Prices as Volumes Slip](http://www.nasdaqpicks.com/wp-content/uploads/2023/07/Dove-Maker-Unilever-Still-Raising-Prices-as-Volumes-Slip-400x400.jpeg)
Dove Maker Unilever Still Raising Prices as Volumes Slip
- By nasdaqpicks.com
- . 25 July 2023
The consumer-goods giant—a bellwether for the global economy and consumer sentiment—boosted prices to make up for soaring commodities and other costs. Source link
![How U.S. Drug Companies Could Tip Europe Into Recession](http://www.nasdaqpicks.com/wp-content/uploads/2023/07/How-US-Drug-Companies-Could-Tip-Europe-Into-Recession-400x400.jpeg)
How U.S. Drug Companies Could Tip Europe Into Recession
- By nasdaqpicks.com
- . 23 July 2023
Swings in Ireland’s pharmaceutical industry, often rooted in tax moves by U.S.-based firms, have outsize impact on European output. Source link
![At Startup That Says Its AI Writes Medical Records, Humans Do a Lot of the Work](http://www.nasdaqpicks.com/wp-content/uploads/2023/07/At-Startup-That-Says-Its-AI-Writes-Medical-Records-Humans-400x400.jpeg)
At Startup That Says Its AI Writes Medical Records, Humans Do a Lot of the Work
- By nasdaqpicks.com
- . 23 July 2023
DeepScribe relies on a team of people to review tech-generated reports, listen to medical conversations and revise the records. Source link
![Big Pharma Bets Big on China](http://www.nasdaqpicks.com/wp-content/uploads/2023/07/Big-Pharma-Bets-Big-on-China-400x400.jpeg)
Big Pharma Bets Big on China
- By nasdaqpicks.com
- . 23 July 2023
China remains attractive to global pharmaceutical companies even as many multinationals shift their focus elsewhere. Source link
![J&J Revenue Up on Surge in Heart Procedures](http://www.nasdaqpicks.com/wp-content/uploads/2023/07/JampJ-Revenue-Up-on-Surge-in-Heart-Procedures-400x400.jpeg)
J&J Revenue Up on Surge in Heart Procedures
- By nasdaqpicks.com
- . 20 July 2023
Net earnings at the pharmaceutical company rose 6.9% to $5.14 billion, or $1.96 a share. Source link
![Tornado Damages Key Pfizer Drugmaking Plant](http://www.nasdaqpicks.com/wp-content/uploads/2023/07/Tornado-Damages-Key-Pfizer-Drugmaking-Plant-400x400.jpeg)
Tornado Damages Key Pfizer Drugmaking Plant
- By nasdaqpicks.com
- . 20 July 2023
The plant in Rocky Mount, N.C., produces a quarter of the sterile injectable medicines used by U.S. hospitals. Source link
Johnson & Johnson Rips Off the Kenvue Band-Aid
A surprisingly early distribution and a stretched valuation hit J&J’s consumer health arm hard. Source link